Thomas Wj Huizinga (Tom W J Huizinga, Twj Huizinga, Tom Wj Huizinga, Tom Huizinga, Tom W J Huizinga, Thomas Huizinga)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 92

Top Venues

RMD open

Annals of the rheumatic diseases

Nature communications

Expert review of clinical immunology

Leiden University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center Feb 01 1993

Netherlands

prof :: Rheumatology

Publications

Stef van der Meulen, Rory Caitlin Monahan, Kyra A Gelderman, Cees van Kooten, Y K Onno Teng, Thomas Wj Huizinga, Gerda M Steup-Beekman, Leendert Adrianus Trouw
Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus. European journal of immunology (2024)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Peter C Taylor, Georg Schett, Thomas Wj Huizinga, Qingmin Wang, Fowzia Ibrahim, Bei Zhou, Sophia G Liva, Jafar Sadik B Shaik, Yuan Xiong, Jocelyn H Leu, Rohit A Panchakshari, Matthew J Loza, Keying Ma, Harman Dhatt, Ricardo Rojo Cella, Chetan S Karyekar, Carolyn A Cuff, Sheng Gao, Kaiyin Fei
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Thomas Wj Huizinga, Sytske Anne Bergstra
Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study. RMD open 10 (2) (2024)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases 83 (4) (2024)
Eva Maria Stork, Danique M H van Rijswijk, Karin Anna van Schie, Max Hoek, Theresa Kissel, Hans Ulrich Scherer, Thomas Wj Huizinga, Albert J R Heck, René E M Toes, Albert Bondt
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nature communications 15 (1) (2024)
Jacopo Ciaffi, Sophie I E Liem, Suzanne Cannegieter, Saad Ahmed, Eva M Hoekstra, Piotr Wiland, Tatsuya Atsumi, Gabriella Szücs, Alexandra Balbir Gurman, László Czirják, Elisabetta Zanatta, Ina Koetter, Joerg Christoph Henes, Marco Matucci Cerinic, Paolo Airò, Francesco Ursini, Thomas Wj Huizinga, Jeska K de Vries-Bouwstra, Eustar Collaborators
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD open 10 (2) (2024)
Wieke M van Oostveen, Thomas Wj Huizinga, Cynthia M Fehres
Pathogenic role of anti-nuclear autoantibodies in systemic sclerosis: Insights from other rheumatic diseases. Immunological reviews (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
Eva Maria Stork, Danique M H van Rijswijk, Karin Anna van Schie, Max Hoek, Theresa Kissel, Hans Ulrich Scherer, Thomas Wj Huizinga, Albert J R Heck, René E M Toes, Albert Bondt
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nature communications 15 (1) (2024)
Jacopo Ciaffi, Sophie I E Liem, Suzanne Cannegieter, Saad Ahmed, Eva M Hoekstra, Piotr Wiland, Tatsuya Atsumi, Gabriella Szücs, Alexandra Balbir Gurman, László Czirják, Elisabetta Zanatta, Ina Koetter, Joerg Christoph Henes, Marco Matucci Cerinic, Paolo Airò, Francesco Ursini, Thomas Wj Huizinga, Jeska K de Vries-Bouwstra, Eustar Collaborators
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD open 10 (2) (2024)
Jacopo Ciaffi, Sophie I E Liem, Suzanne Cannegieter, Saad Ahmed, Eva M Hoekstra, Piotr Wiland, Tatsuya Atsumi, Gabriella Szücs, Alexandra Balbir Gurman, László Czirják, Elisabetta Zanatta, Ina Koetter, Joerg Christoph Henes, Marco Matucci Cerinic, Paolo Airò, Francesco Ursini, Thomas Wj Huizinga, Jeska K de Vries-Bouwstra, Eustar Collaborators
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort. RMD open 10 (2) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
Peter C Taylor, Georg Schett, Thomas Wj Huizinga, Qingmin Wang, Fowzia Ibrahim, Bei Zhou, Sophia G Liva, Jafar Sadik B Shaik, Yuan Xiong, Jocelyn H Leu, Rohit A Panchakshari, Matthew J Loza, Keying Ma, Harman Dhatt, Ricardo Rojo Cella, Chetan S Karyekar, Carolyn A Cuff, Sheng Gao, Kaiyin Fei
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Thomas Wj Huizinga, Sytske Anne Bergstra
Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study. RMD open 10 (2) (2024)
Mikhail Y Volkov, Arieke Suzanna Berendina Kampstra, Karin A J van Schie, Anouk G van Mourik, Joanneke C Kwekkeboom, Arnoud de Ru, Peter A van Veelen, Thomas Wj Huizinga, René E M Toes, Diane van der Woude
Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response. RMD open 10 (3) (2024)
Joy Ardjuna van der Pol, Cornelia F Allaart, Willem F Lems, Sjoerd M van der Kooij, Thomas Wj Huizinga, Sytske Anne Bergstra
Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study. RMD open 10 (2) (2024)
Peter C Taylor, Georg Schett, Thomas Wj Huizinga, Qingmin Wang, Fowzia Ibrahim, Bei Zhou, Sophia G Liva, Jafar Sadik B Shaik, Yuan Xiong, Jocelyn H Leu, Rohit A Panchakshari, Matthew J Loza, Keying Ma, Harman Dhatt, Ricardo Rojo Cella, Chetan S Karyekar, Carolyn A Cuff, Sheng Gao, Kaiyin Fei
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. RMD open 10 (2) (2024)
Eva Maria Stork, Danique M H van Rijswijk, Karin Anna van Schie, Max Hoek, Theresa Kissel, Hans Ulrich Scherer, Thomas Wj Huizinga, Albert J R Heck, René E M Toes, Albert Bondt
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nature communications 15 (1) (2024)
Peter C Taylor, Georg Schett, Thomas Wj Huizinga, Qingmin Wang, Fowzia Ibrahim, Bei Zhou, Sophia G Liva, Jafar Sadik B Shaik, Yuan Xiong, Jocelyn H Leu, Rohit A Panchakshari, Matthew J Loza, Keying Ma, Harman Dhatt, Ricardo Rojo Cella, Chetan S Karyekar, Carolyn A Cuff, Sheng Gao, Kaiyin Fei
Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study. RMD open 10 (2) (2024)
Eva Maria Stork, Danique M H van Rijswijk, Karin Anna van Schie, Max Hoek, Theresa Kissel, Hans Ulrich Scherer, Thomas Wj Huizinga, Albert J R Heck, René E M Toes, Albert Bondt
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nature communications 15 (1) (2024)
Eva Maria Stork, Danique M H van Rijswijk, Karin Anna van Schie, Max Hoek, Theresa Kissel, Hans Ulrich Scherer, Thomas Wj Huizinga, Albert J R Heck, René E M Toes, Albert Bondt
Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis. Nature communications 15 (1) (2024)
Michelle D van den Beukel, Tineke J van Wesemael, Anna Titia W Hoogslag, Nicole V Borggreven, Thomas Wj Huizinga, Annette H M van der Helm van Mil, René E M Toes, Diane van der Woude, Leendert Adrianus Trouw
Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association. RMD open 9 (4) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Sascha Louise Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W A van Suijlekom-Smit, Marion A J van Rossum, Yvonne Koopman, Rebecca Ten Cate, Danielle M C Brinkman, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Patterns of clinical joint inflammation in juvenile idiopathic arthritis. RMD open 9 (1) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Sophie I E Liem, Jacopo Ciaffi, Nina Marijn van Leeuwen, Maaike Boonstra, Saad Ahmed, Liesbeth J J Beaart-van de Voorde, Anja Corsel, Talitha Dhondai, Maarten K Ninaber, J J Miranda Geelhoed-Veltman, Marlies E Heuvers, Maarten E Tushuizen, Nina Ajmone Marsan, Philippine Kiès, Anne A Schouffoer, Thomas Wj Huizinga, Cornelia F Allaart, Jeska De Vries-Bouwstra
Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort. RMD open 9 (2) (2023)
Sascha Louise Heckert, Johanna Maria Maassen, S le Cessie, Y P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Thomas Wj Huizinga, Sytske Anne Bergstra, Cornelia F Allaart
Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort. Annals of the rheumatic diseases (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Tineke J van Wesemael, Sanne Reijm, Atsushi Kawakami, Annemarie L Dorjée, Gerrie Stoeken, Takahiro Maeda, Shin-Ya Kawashiri, Thomas Wj Huizinga, Mami Tamai, René E M Toes, Diane van der Woude
IgM antibodies against acetylated proteins as a possible starting point of the anti-modified protein antibody response in rheumatoid arthritis. Annals of the rheumatic diseases (2023)
Sophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, Brigitte A Wevers, René E M Toes, Cornelia F Allaart, Thomas Wj Huizinga, Hans Ulrich Scherer, Jeska K De Vries-Bouwstra
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. RMD open 9 (1) (2023)
Sophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, Brigitte A Wevers, René E M Toes, Cornelia F Allaart, Thomas Wj Huizinga, Hans Ulrich Scherer, Jeska K De Vries-Bouwstra
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. RMD open 9 (1) (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Sophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, Brigitte A Wevers, René E M Toes, Cornelia F Allaart, Thomas Wj Huizinga, Hans Ulrich Scherer, Jeska K De Vries-Bouwstra
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. RMD open 9 (1) (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
Sascha Louise Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W A van Suijlekom-Smit, Marion A J van Rossum, Yvonne Koopman, Rebecca Ten Cate, Danielle M C Brinkman, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Patterns of clinical joint inflammation in juvenile idiopathic arthritis. RMD open 9 (1) (2023)
Sascha Louise Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, Dieneke Schonenberg-Meinema, Lisette W A van Suijlekom-Smit, Marion A J van Rossum, Yvonne Koopman, Rebecca Ten Cate, Danielle M C Brinkman, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Patterns of clinical joint inflammation in juvenile idiopathic arthritis. RMD open 9 (1) (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Sascha Louise Heckert, Sytske Anne Bergstra, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, Willem F Lems, Xanthe Marijn Edmée Matthijssen, Maikel van Oosterhout, Thomas Wj Huizinga, Cornelia F Allaart
Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD open 9 (1) (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Kevin L Winthrop, John Dudley Isaacs, Phillip J Mease, Dimitrios T Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R Lories, Daniel Aletaha, Iain B McInnes, Thomas Wj Huizinga, Reinhard E Voll, Ellen M Gravallese, Ferry C Breedveld, Josef S Smolen
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022. Annals of the rheumatic diseases (2023)
Joy Ardjuna van der Pol, Gülşah Akdemir, Marianne van den Broek, Linda Dirven, Pit J S M Kerstens, Willem F Lems, Iris M Markusse, Thomas Wj Huizinga, Cornelia F Allaart
Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial. RMD open 9 (2) (2023)
Thomas Wj Huizinga, Ernest Choy, Amy Praestgaard, Hubert van Hoogstraten, Patrick R LaFontaine, Patricia Guyot, Daniel Aletaha, Ulf Müller-Ladner, Yoshiya Tanaka, Jeffrey R Curtis, Roy Fleischmann
Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison. Rheumatology and therapy (2023)
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Signe Holm Nielsen, Anne-Christine Bay-Jensen, Paul Emery, Yoshiya Tanaka, Vivian P Bykerk, Clifton O Bingham, Thomas Wj Huizinga, Roy M Fleischmann, Jinqi Liu
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis. RMD open 8 (2) (2023)
Sophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, Brigitte A Wevers, René E M Toes, Cornelia F Allaart, Thomas Wj Huizinga, Hans Ulrich Scherer, Jeska K De Vries-Bouwstra
Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. RMD open 9 (1) (2023)
Corrie M Wortel, Sophie I E Liem, Nina Marijn van Leeuwen, Maaike Boonstra, Cynthia M Fehres, Lauran Stöger, Thomas Wj Huizinga, René E M Toes, Jeska De Vries-Bouwstra, Hans Ulrich Scherer
Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis. RMD open 9 (3) (2023)
Kevin L Winthrop, Philip Mease, Andreas Kerschbaumer, Reinhard E Voll, Ferdinand C Breedveld, Josef S Smolen, Jacques-Eric Gottenberg, Xenofon Baraliakos, Hans P Kiener, Daniel Aletaha, John Dudley Isaacs, Maya H Buch, Mary K Crow, Jonathan Kay, Leslie J Crofford, Ronald F Van Vollenhoven, Caroline Ospelt, Stefan Siebert, Margreet Kloppenburg, Iain B McInnes, Thomas Wj Huizinga, Ellen M Gravallese
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023. Annals of the rheumatic diseases (2023)
Theodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, Peter Mannfolk, Olof Strandberg, Andreas Jönsen, Anders Bengtsson, Markus Nilsson, Linda Knutsson, Jimmy Lätt, Gerda M Steup-Beekman, Thomas Wj Huizinga, Mark A van Buchem, Itamar Ronen, Pia C Sundgren
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach. Scientific reports 12 (1) (2022)
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert B M Landewe, Johannes Jw Bijlsma, Andreas Kerschbaumer, René Westhovens, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases 81 (7) (2022)
Theresa Kissel, Changrong Ge, Lise Hafkenscheid, Joanneke C Kwekkeboom, Linda M Slot, Marco Cavallari, Yibo He, Karin Anna van Schie, Rochelle D Vergroesen, Arieke Suzanna Berendina Kampstra, Sanne Reijm, Gerrie Stoeken-Rijsbergen, Carolien A M Koeleman, Lennard M Voortman, Laura H Heitman, Bingze Xu, Ger J M Pruijn, Dana L E Vergoossen, Theo Rispens, Thomas Wj Huizinga, Hans Ulrich Scherer, Michael Reth, Rickard Holmdahl, René E M Toes
Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation. Science advances 8 (6) (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Bernardo D'Onofrio, Annette van der Helm-van Mil, Thomas Wj Huizinga, Elise van Mulligen
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis. Expert review of clinical immunology 19 (2) (2022)
Lotte van Ouwerkerk, Diane van der Woude, Theo Rispens, Cornelia F Allaart, Thomas Wj Huizinga
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort. Scandinavian journal of rheumatology (2022)
Bernardo D'Onofrio, Annette van der Helm-van Mil, Thomas Wj Huizinga, Elise van Mulligen
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis. Expert review of clinical immunology 19 (2) (2022)
Theodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, Peter Mannfolk, Olof Strandberg, Andreas Jönsen, Anders Bengtsson, Markus Nilsson, Linda Knutsson, Jimmy Lätt, Gerda M Steup-Beekman, Thomas Wj Huizinga, Mark A van Buchem, Itamar Ronen, Pia C Sundgren
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach. Scientific reports 12 (1) (2022)
Ahmed Al Hasan, Floor Reimann, Nic J G M Veeger, Sytske Anne Bergstra, Dan Zhang, Arno R Bourgonje, Lidy Hendriks, Titus Beertsen, Liliane Zari Riofrio, Freke R Wink, Annemarie Schilder, Thomas Wj Huizinga, Reinhard Bos
Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry. Rheumatology international 42 (11) (2022)
Bernardo D'Onofrio, Annette van der Helm-van Mil, Thomas Wj Huizinga, Elise van Mulligen
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis. Expert review of clinical immunology 19 (2) (2022)
Kazuyoshi Ishigaki, Saori Sakaue, Chikashi C Terao, Yang Luo, Kyuto Sonehara, Kensuke Yamaguchi, Tiffany Amariuta, Chun Lai Too, Vincent A Laufer, Ian C Scott, Sebastien Viatte, Meiko Takahashi, Koichiro Ohmura, Akira Murasawa, Motomu Hashimoto, Hiromu Ito, Mohammed Hammoudeh, Samar Al Emadi, Basel K Masri, Hussein Halabi, Humeira Badsha, Imad W Uthman, Xin Wu, Li Lin, Ting Li, Darren Plant, Richard B Warren, Gisela Orozco, Suzanne M M Verstappen, John David Bowes, Alexander J MacGregor, Suguru Honda, Masaru Koido, Kohei Tomizuka, Yoichiro Kamatani, Hiroaki Tanaka, Eiichi Tanaka, Akari Suzuki, Yuichi Maeda, Kenichi Yamamoto, Satoru Miyawaki, Gang Xie, Jinyi Zhang, Christopher Ian Amos, Edward Keystone, Gertjan Wolbink, Irene van der Horst-Bruinsma, Jing Cui, Katherine P Liao, Robert J Carroll, Hye-Soon Lee, So-Young Bang, Katherine A Siminovitch, Niek De Vries, Lars Alfredsson, Solbritt Rantapää Dahlqvist, Elizabeth W Karlson, Sang-Cheol Bae, Robert P Kimberly, Jeffrey C Edberg, Xavier Mariette, Thomas Wj Huizinga, Philippe Dieude, Matthias Schneider, Martin Kerick, Joshua C Denny, null null, Koichi Matsuda, Keitaro Matsuo, Tsuneyo Mimori, Fumihiko Matsuda, Keishi Fujio, Yoshiya Tanaka, Atsushi Kumanogoh, Matthew Traylor, Cathryn M Lewis, Stephen Eyre, Huji Xu, Richa Saxena, Thurayya Arayssi, Yuta Kochi, Katsunori Ikari, Masayoshi Harigai, Peter K Gregersen, Kazuhiko Yamamoto, S Louis Bridges, Leonid Padyukov, Javier Martín, Lars Klareskog, Yukinori Okada, Soumya Raychaudhuri
Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nature genetics 54 (11) (2022)
Theodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, Peter Mannfolk, Olof Strandberg, Andreas Jönsen, Anders Bengtsson, Markus Nilsson, Linda Knutsson, Jimmy Lätt, Gerda M Steup-Beekman, Thomas Wj Huizinga, Mark A van Buchem, Itamar Ronen, Pia C Sundgren
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach. Scientific reports 12 (1) (2022)
Nikolet K den Hollander, Marloes Verstappen, Thomas Wj Huizinga, Annette H M van der Helm van Mil
Management of contemporary early undifferentiated arthritis: data on EULAR's recommendation on the risk of persistent disease. Annals of the rheumatic diseases 81 (5) (2022)
Rory Caitlin Monahan, Michelle D van den Beukel, Nicole V Borggreven, Rolf Fronczek, Thomas Wj Huizinga, Margreet Kloppenburg, Gerda M Steup-Beekman, Leendert Adrianus Trouw
Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations. RMD open 8 (1) (2022)
Theodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, Peter Mannfolk, Olof Strandberg, Andreas Jönsen, Anders Bengtsson, Markus Nilsson, Linda Knutsson, Jimmy Lätt, Gerda M Steup-Beekman, Thomas Wj Huizinga, Mark A van Buchem, Itamar Ronen, Pia C Sundgren
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach. Scientific reports 12 (1) (2022)
S C Heslinga, Charlotte E Teunissen, Rabia Agca, Diane van der Woude, Thomas Wj Huizinga, Jacob M van Laar, Alfons A den Broeder, Willem F Lems, Michael T Nurmohamed
NT-proBNP and sRAGE levels in early rheumatoid arthritis. Scandinavian journal of rheumatology (2022)
Bernardo D'Onofrio, Annette van der Helm-van Mil, Thomas Wj Huizinga, Elise van Mulligen
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis. Expert review of clinical immunology (2022)
Theodor Rumetshofer, Francesca Inglese, Jeroen de Bresser, Peter Mannfolk, Olof Strandberg, Andreas Jönsen, Anders Bengtsson, Markus Nilsson, Linda Knutsson, Jimmy Lätt, Gerda M Steup-Beekman, Thomas Wj Huizinga, Mark A van Buchem, Itamar Ronen, Pia C Sundgren
Tract-based white matter hyperintensity patterns in patients with systemic lupus erythematosus using an unsupervised machine learning approach. Scientific reports 12 (1) (2022)
Bernardo D'Onofrio, Annette van der Helm-van Mil, Thomas Wj Huizinga, Elise van Mulligen
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis. Expert review of clinical immunology (2022)
Marloes Verstappen, Thomas Wj Huizinga, Annette Hm van der Helm-van Mil
No excess mortality in contemporary undifferentiated arthritis, in contrast to rheumatoid arthritis: a study with a follow-up of at least 10 years. Annals of the rheumatic diseases 81 (8) (2022)
Josephine A M P Amkreutz, Emma C de Moel, Lisa Theander, Minna Willim, Lotte Heimans, Jan-Åke Nilsson, Magnus K Karlsson, Thomas Wj Huizinga, Kristina E Åkesson, Lennart T H Jacobsson, Cornelia F Allaart, Carl Turesson, Diane van der Woude
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis. Arthritis & rheumatology (Hoboken, N.J.) 73 (6) (2021)
Lotte van Ouwerkerk, Andrea E van der Meulen-de Jong, Maarten K Ninaber, Y K Onno Teng, Thomas Wj Huizinga, Cornelia F Allaart
Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs. Annals of the rheumatic diseases 80 (10) (2021)
Sytske Anne Bergstra, Cornelia F Allaart, David Vega-Morales, Marieke De Buck, Elizabeth Murphy, Karen Salomon Escoto, Thomas Wj Huizinga
Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registry. RMD open 6 (2) (2021)
Theresa Kissel, Tineke J van Wesemael, Anders Lundquist, Heidi Kokkonen, Atsushi Kawakami, Mami Tamai, Dirkjan van Schaardenburg, Manfred Wuhrer, Thomas Wj Huizinga, Hans Ulrich Scherer, Diane van der Woude, Solbritt Rantapää Dahlqvist, René E M Toes
Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA. Annals of the rheumatic diseases (2021)
Veerle F A M Derksen, Theresa Kissel, Femke B G Lamers-Karnebeek, Arie E van der Bijl, Annemarie C Venhuizen, Thomas Wj Huizinga, René E M Toes, Anna H E Roukens, Diane van der Woude
Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Annals of the rheumatic diseases (2021)
Jonathan Kay, Masayoshi Harigai, Josh Rancourt, Christina Dickson, Thomas Melby, Maher Issa, Inmaculada de la Torre, Yoshitaka Isaka, Anabela Cardoso, Chadi Saifan, Edward C Keystone, Ronald F Van Vollenhoven, Jon T Giles, Thomas Wj Huizinga, Joel M Kremer
Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib. RMD open 6 (3) (2021)
Sytske Anne Bergstra, Joy A Van Der Pol, Naghmeh Riyazi, Yvonne P M Goekoop-Ruiterman, Pit J S M Kerstens, Willem Lems, Thomas Wj Huizinga, Cornelia F Allaart
Earlier is better when treating rheumatoid arthritis: but can we detect a window of opportunity? RMD open 6 (1) (2021)
Nina Marijn van Leeuwen, Marc Maurits, Sophie Liem, Jacopo Ciaffi, Nina Ajmone Marsan, Maarten Ninaber, Cornelia Allaart, Henrike Gillet van Dongen, Robbert Goekoop, Thomas Wj Huizinga, Rachel Knevel, Jeska De Vries-Bouwstra
New risk model is able to identify patients with a low risk of progression in systemic sclerosis. RMD open 7 (2) (2021)
Rory Caitlin Monahan, Francesca Inglese, Huub Middelkoop, Mark van Buchem, Thomas Wj Huizinga, Margreet Kloppenburg, Itamar Ronen, Gerda M Steup-Beekman, Jeroen de Bresser
White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms. RMD open 7 (2) (2021)
Johanna Maria Maassen, Raquel Dos Santos Sobrín, Sytske Anne Bergstra, Robbert J Goekoop, Thomas Wj Huizinga, Cornelia F Allaart
Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies. Annals of the rheumatic diseases 80 (9) (2021)
Hendy Kristyanto, Nienke J Blomberg, Linda M Slot, Ellen I H van der Voort, Priscilla F Kerkman, Aleida Bakker, Leonie E Burgers, Robin M Ten Brinck, Annette H M van der Helm-van Mil, Hergen Spits, Dominique L Baeten, Thomas Wj Huizinga, René E M Toes, Hans Ulrich Scherer
Persistently activated, proliferative memory autoreactive B cells promote inflammation in rheumatoid arthritis. Science translational medicine 12 (570) (2021)
Sascha Louise Heckert, Sytske Anne Bergstra, Xanthe Marijn Edmée Matthijssen, Yvonne P M Goekoop-Ruiterman, Faouzia Fodili, Saskia Ten Wolde, Cornelia F Allaart, Thomas Wj Huizinga
Joint inflammation tends to recur in the same joints during the rheumatoid arthritis disease course. Annals of the rheumatic diseases (2021)
G Esther A Habers, Annette H M van der Helm van Mil, Dieuwke S Veldhuijzen, Cornelia F Allaart, Erno Vreugdenhil, Daniëlle E J Starreveld, Thomas Wj Huizinga, Andrea W M Evers
Earlier chronotype in patients with rheumatoid arthritis. Clinical rheumatology 40 (6) (2021)
Rachel Knevel, Saskia Le Cessie, Chikashi C Terao, Kamil Slowikowski, Jing Cui, Thomas Wj Huizinga, Karen H Costenbader, Katherine P Liao, Elizabeth W Karlson, Soumya Raychaudhuri
Using genetics to prioritize diagnoses for rheumatology outpatients with inflammatory arthritis. Science translational medicine 12 (545) (2021)
Thomas Wj Huizinga, Yoshifumi Torii, Rafael Muniz
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity. Rheumatology and therapy 8 (1) (2020)
Thomas Wj Huizinga, V Michael Holers, Jennifer Anolik, Michael B Brenner, Christopher Dominic Buckley, Vivian Bykerk, Sean E Connolly, Kevin D Deane, Jianping Guo, Martin Hodge, Steve Hoffmann, Frank Nestle, Costantino Pitzalis, Soumya Raychaudhuri, Kazuhiko Yamamoto, Zhanguo Li, Lars Klareskog
Disruptive innovation in rheumatology: new networks of global public-private partnerships are needed to take advantage of scientific progress. Annals of the rheumatic diseases 79 (5) (2020)
Theresa Kissel, S Reijm, L M Slot, M Cavallari, C M Wortel, R D Vergroesen, G Stoeken-Rijsbergen, J C Kwekkeboom, Arieke Suzanna Berendina Kampstra, Ewn Levarht, J W Drijfhout, H Bang, K M Bonger, Gmc Janssen, P A van Veelen, Thomas Wj Huizinga, H U Scherer, M Reth, René E M Toes
Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications. Annals of the rheumatic diseases 79 (4) (2020)
Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten P T de Wit, Daniel Aletaha, Martin Aringer, John Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Mario Humberto Cardiel, Diederik De Cock, Catalin Codreanu, Maurizio Cutolo, Christopher John Edwards, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques-Eric Gottenberg, Merete Lund Hetland, Thomas Wj Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller-Ladner, Eduardo F Mysler, José António Pereira Da Silva, Gyula Poór, Janet E Pope, Andrea Rubbert-Roth, Adeline Ruyssen-Witrand, Kenneth G Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Annals of the rheumatic diseases 79 (6) (2020)
Xanthe Marijn Edmée Matthijssen, Thomas Wj Huizinga, Annette H M van der Helm van Mil
Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population. Annals of the rheumatic diseases (2020)
Tjardo D Maarseveen, Timo Meinderink, Marcel J T Reinders, Johannes Knitza, Thomas Wj Huizinga, Arnd Kleyer, David Simon, Erik Ben van den Akker, Rachel Knevel
Machine Learning Electronic Health Record Identification of Patients with Rheumatoid Arthritis: Algorithm Pipeline Development and Validation Study. JMIR medical informatics 8 (11) (2020)
Sandra van Bijnen, Jeska de Vries-Bouwstra, Cornelia H van den Ende, Maaike Boonstra, Lucie Kroft, Bram Geurts, Miranda Snoeren, Anne Schouffoer, Julia Spierings, Jacob M van Laar, Thomas Wj Huizinga, Alexandre Voskuyl, Erik Marijt, Walter van der Velden, Frank Hj van den Hoogen, Madelon C Vonk
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study. Annals of the rheumatic diseases 79 (8) (2020)

Thomas Wj Huizinga.css-eqlu8i{font-size:small;padding-left:4px;} (Tom W J Huizinga, Twj Huizinga, Tom Wj Huizinga, Tom Huizinga, Tom W J Huizinga, Thomas Huizinga)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Wj Huizinga (Tom W J Huizinga, Twj Huizinga, Tom Wj Huizinga, Tom Huizinga, Tom W J Huizinga, Thomas Huizinga)